SCHEMBL7079820

SCHEMBL7079820

S=C(c1ccc(Nc2cccnc2)cc1Cl)c1sccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
LMNA P02545 3/20 0.44
MAPT P10636 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
NAMPT P43490 2/20 0.39
NPC1 O15118 3/20 0.39
HTT P42858 2/20 0.39
TP53 P04637 1/20 0.39
KIF11 P52732 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RAB9A P51151 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.37
GRM5 P41594 1/20 0.37
HPGD P15428 1/20 0.37
CYP11B2 P19099 3/20 0.36
GLA P06280 1/20 0.36
CSF1R P07333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7083156 0.86 NAMPT (0.44) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL7076675 0.85 MAPK13 (0.47) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL7075667 0.84 NAMPT (0.38) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL7075671 0.84 NAMPT (0.38) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL7040292 0.78 MAPK14 (0.54) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL7593935 0.77 MAPK14 (0.35) MEN1KMT2AMAPTKDM4ENAMPT
SCHEMBL7082009 0.77 ADRA2A (0.43) LMNAMAPTALDH1A1KDM4EHTT
SCHEMBL7082053 0.75 MAPK14 (0.55) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL7074987 0.75 MAPK14 (0.56) KMT2AALDH1A1
SCHEMBL7082231 0.73 ALDH1A1 (0.41) MEN1KMT2AMAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MEN1 4824/4885KMT2A 1701/4885LMNA 3287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.